Price
Financials
Consolidated, Rs crore| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 3,095 | 3,863 | 3,662 |
| Expenses | 2,768 | 3,310 | 3,154 |
| Operating Profit | 327 | 553 | 508 |
| OPM % | 11% | 14% | 14% |
| Other Income | 267 | -1,289 | 99 |
| Interest | 461 | 440 | 207 |
| Depreciation | 199 | 212 | 225 |
| Profit before tax | -66 | -1,388 | 175 |
| Tax % | 120% | 40% | 31% |
| Net Profit | -145 | -1,939 | 121 |
| EPS in Rs | -14,200.00 | -191,300.00 | 0.31 |
| Mar 2026 | |
|---|---|
| Sales | 13,587 |
| Expenses | 12,460 |
| Operating Profit | 1,127 |
| OPM % | 8% |
| Other Income | -672 |
| Interest | 1,816 |
| Depreciation | 801 |
| Profit before tax | -2,162 |
| Tax % | 36% |
| Net Profit | -2,935 |
| EPS in Rs | -288,200.00 |
| Dividend Payout % | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | % | ||
| Compounded Profit Growth | % | % | % | % | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2026 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Borrowings | |
| Other Liabilities | |
| Total Liabilities | |
| Fixed Assets | |
| CWIP | |
| Investments | |
| Other Assets | |
| Total Assets |
| Mar 2026 | |
|---|---|
| Cash from Operating Activity | |
| Cash from Investing Activity | |
| Cash from Financing Activity | |
| Net Cash Flow | |
| Free Cash Flow | |
| CFO/OP |
| Mar 2026 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
| Jun 2026 | |
|---|---|
| Promoters | 56.38% |
| FIIs | 5.38% |
| DIIs | 12.09% |
| Government | 0.06% |
| Public | 25.92% |
| Others | 0.16% |
| No. of Shareholders | 22,84,228 |
Fundamentals
Market Cap₹ 12,846 Cr.
Current Price₹ 32.8
Book Value₹
ROCE%
ROE%
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)%
Consolidated figures.
Ownership
Promoter holding56.38%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | VISL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.0% | -2.8% | -0.2 pts |
| 1 month | -12.1% | -6.8% | -5.4 pts |
| 3 months | -23.1% | -7.6% | -15.5 pts |
67 mutual fund schemes hold about ₹186 Cr.
Over three months 17 bought more and 48 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| ICICI Pru Multi Cap Fund | 0.22% | 42 | +26% |
| ICICI Pru Multi Cap Fund | 0.22% | 41 | +26% |
| ICICI Pru Commodities Fund | 0.40% | 17 | +23% |
| ICICI Pru Large & Mid Cap Fund | 0.04% | 14 | +24% |
| ICICI Pru Mid Cap Fund | 0.15% | 12 | +27% |
| ICICI Pru Mid Cap Fund | 0.15% | 12 | +27% |
| SBI Large Cap Fundd | 0.02% | 12 | -59% |
| SBI Dividend Yield Fund | 0.12% | 10 | +34% |
| UTI Large & Mid Cap Fund | 0.12% | 8 | +30% |
| UTI Aggressive Hybrid Fund | 0.11% | 7 | +34% |
| UTI Multi Asset Allocation Fund | 0.04% | 3 | +33% |
| UTI Retirement Fund | 0.06% | 3 | +35% |
| Aditya Birla SL Mfg. Equity Fund | 0.14% | 2 | +19% |
| Edelweiss Balanced Advantage Fund(Q | 0.01% | 2 | -66% |
| UTI Quant Fund | 0.04% | 1 | +6% |
| UTI Balanced Advantage Fund | 0.02% | 1 | +38% |
| Edelweiss Equity Savings Fund(M | 0.02% | 0 | +19% |
| Edelweiss Equity Savings Fund(M | 0.02% | 0 | +19% |
| Aditya Birla SL Retirement Fund-40 | 0.10% | 0 | +33% |
| Bank of India Large Cap Fund | 0.02% | 0 | -84% |
| Nippon India Flexi Cap Fund | 0.00% | 0 | -100% |
| Baroda BNP Paribas Balanced Advantage Fund | 0.00% | 0 | -100% |
| Bajaj Finserv Balanced Advantage Fund | 0.00% | 0 | -100% |
| Bajaj Finserv Large Cap Fund | 0.00% | 0 | -100% |
| 360 ONE Balanced Hybrid Fund | 0.00% | 0 | -100% |
Red flags
| look | Regulator order or action Regulator order or action 2026-09-26: Please refer the enclosed intimation under Regulation 30 of LODR. |
| look | Auditor change Auditor change 2026-07-01: Vedanta Iron and Steel Limited has informed the Exchange regarding Change in Auditors of the company. |
| look | On NSE surveillance On NSE surveillance: ASM long-term |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Insider trades
NSE insider and takeover-code disclosures| Date | Who | Role | Side | Shares | Value | How |
|---|---|---|---|---|---|---|
| 2026-09-16 | GLAS Agency (Hong Kong) Limited (a | Acquirer | buy | 2,204,724,753 | SAST Others |
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| JSW Steel Ltd | 311,160 | 25.8 | 11.0 % |
| Tata Steel Ltd | 234,690 | 19.8 | 12.5 % |
| Jindal Steel Ltd | 115,270 | 37.3 | 9.70 % |
| Steel Authority of India Ltd | 75,101 | 15.6 | 7.92 % |
| Jindal Stainless Ltd | 60,867 | 18.5 | 19.3 % |
| Sarda Energy & Minerals Ltd | 17,631 | 15.7 | 16.9 % |
| NMDC Steel Ltd | 12,247 | 146 | 3.06 % |
| Sandur Manganese & Iron Ores Ltd | 8,881 | 12.0 | 24.2 % |
| Jai Balaji Industries Ltd | 5,779 | 39.5 | 9.57 % |
| Prakash Industries Ltd | 2,178 | 6.96 | 9.56 % |
| Manaksia Steels Ltd | 733 | 13.5 | 13.4 % |
| Scan Steels Ltd | 304 | 13.4 | 7.05 % |
| KIC Metaliks Ltd | 108 | 33.6 | 4.01 % |
| Ankit Metal & Power Ltd | 27 | -34.2 % |
No bulk or block deals on record.
No corporate actions on record.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
EPS in the scrip is zero (4 trailing quarters)Long Term Additional Surveillance Measure (Long Term ASM): stage 1